Philips Acquire InnerCool Therapies to Expand Care Cycle Offering


InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM), will be acquired in an asset purchase transaction for 11.25 million dollars, as well as the transfer of approximately 1.5 million dollars in trade payables. The transaction will reinforce Philips

Published on : Thu, 16 Jul 2009


Print as PDF
InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM), will be acquired in an asset purchase transaction for 11.25 million do

No comment


Please login to leave a comment...